Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis.
- Bidard, François-Clément
- Michiels, Stefan
- Riethdorf, Sabine
- Mueller, Volkmar
- Esserman, Laura J
- Lucci, Anthony
- Naume, Bjorn
- Horiguchi, Jun
- Gisbert-Criado, Rafael
- Sleijfer, Stefan
- Toi, Masakazu
- Garcia-Saenz, Jose A
- Hartkopf, Andreas
- Generali, Daniele
- Rothé, Françoise
- Smerage, Jeffrey
- Muinelo-Romay, Laura
- Stebbing, Justin
- Viens, Patrice
- Magbanua, Mark Jesus MJM
- Hall, Carolyn S
- Engebraaten, Olav
- Takata, Daisuke
- Vidal-Martínez, José
- Onstenk, Wendy
- Fujisawa, Noriyoshi
- Diaz-Rubio, Eduardo
- Tarantino, Franca
- Cappelletti, M L
- Ignatiadis, Michail
- Proudhon, Charlotte
- Wolf, Denise M
- Bauldry, Jessica JB
- Borgen, E
- Nagaoka, Rin
- Carañana, Vicente
- Kraan, Jaco
- Maestro, Marisa
- Brucker, Sara Yvonne
- Weber, Karsten
- Reyal, Fabien
- Amara, Dominic
- Karhade, Mandar MG
- Mathiesen, Randi RR
- Tokiniwa, Hideaki
- Llombart-Cussac, Antonio
- Meddis, Alessandra
- Blanche, Paul
- d'Hollander, Koenraad
- Cottu, Paul
- Park, John W
- Loibl, Sibylle
- Latouche, Aurelien
- Pierga, Jean-Yves
- Pantel, Klaus
DOIAbstract
We conducted a meta-analysis in nonmetastatic breast cancer patients treated by neoadjuvant chemotherapy (NCT) to assess the clinical validity of circulating tumor cell (CTC) detection as a prognostic marker.SCOPUS: ar.jinfo:eu-repo/semantics/publishe
Add to ORKG